Clindamycin-associated pseudomembranous colitis: a potentially fatal adverse drug reaction

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Clinical Pharmacology

Background:

• Clindamycin is frequently prescribed for various infections.
• Antibiotic-associated colitis is a known complication of antimicrobial therapy.
• Pseudomembranous colitis represents a severe form of this complication.

Purpose of the Study:

• To inform clinicians about potential adverse reactions to clindamycin.
• To describe the clinical presentation of pseudomembranous colitis.
• To review existing literature on clindamycin-induced colitis.

Main Methods:

• Literature review of studies and case reports on clindamycin use and colitis.
• Analysis of clinical symptoms associated with pseudomembranous colitis.
• Synthesis of information regarding diagnosis and management.

Main Results:

• Pseudomembranous colitis is a significant, potentially fatal adverse effect of clindamycin.
• Clinical symptoms include diarrhea, abdominal pain, and fever.
• Early recognition and intervention are crucial for patient outcomes.

Conclusions:

• Clinicians must maintain a high index of suspicion for pseudomembranous colitis in patients treated with clindamycin.
• Awareness of clinical symptoms aids in prompt diagnosis.
• Understanding this risk is vital for safe clindamycin prescribing.